There are no quality or safety issues with the medications, so patients should continue to take them as prescribed, the companies said. The recall was only issued because the blister packaging used to contain the drugs doesn’t meet U.S. federal requirements for child resistance, which poses a threat to child safety. There has been one report of a child ingesting haloperidol, an antipsychotic medication, from a blister pack.
All affected products were sold nationwide at clinics and pharmacies between September 2016 and June 2018.
The recalled products include various lots of the following:
- Zofran ODT
- Entresto
- Azithromycin tablets
- Donepezil ODT
- Haloperidol
- Imipramine HCl
- Isosorbide Dinitrate
- Naratriptan tablets
- Ondansetron ODT
- Ondansetron tablets
- Perphenazine
- Risperidone ODT
Find the full list of recalled products with their dosage and lot numbers here.
More articles on pharmacy:
Walgreens revamps pharmacist training after woman denied medicine: 7 things to know
Pfizer stock value dips after Trump’s tweet
Pfizer hikes price of 100 drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
